UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial

Circulation (New York, N.Y.), 2021-01, Vol.143 (4), p.337-349

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity

Circulation (New York, N.Y.), 2017-11, Vol.136 (21), p.2085-2087

2017

Link zum Volltext

Verfügbarkeit prüfen

Cardiorenal Syndrome Revisited

Circulation (New York, N.Y.), 2018-08, Vol.138 (9), p.929-944

2018

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction

Circulation (New York, N.Y.), 2020-09, Vol.142 (13), p.1236-1245

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

Circulation (New York, N.Y.), 2021-10, Vol.144 (16), p.1284-1294

2021

Link zum Volltext

Verfügbarkeit prüfen

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Circulation (New York, N.Y.), 2022-01, Vol.145 (3), p.184-193

2022

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase

Circulation (New York, N.Y.), 2020-12, Vol.142 (25), p.2443-2455

2020

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

Circulation (New York, N.Y.), 2019-07, Vol.140 (4), p.293-302

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial

Circulation (New York, N.Y.), 2022-07, Vol.146 (4), p.279-288

2022

Link zum Volltext

Verfügbarkeit prüfen

Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry

Circulation (New York, N.Y.), 2020-01, Vol.141 (4), p.243-259

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction

Circulation (New York, N.Y.), 2021-09, Vol.144 (11), p.859-869

2021

Link zum Volltext

Verfügbarkeit prüfen

Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement

Circulation (New York, N.Y.), 2018-09, Vol.138 (10), p.971-985

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction

Circulation (New York, N.Y.), 2016-04, Vol.133 (15), p.1484-1497

2016

Link zum Volltext

Verfügbarkeit prüfen

Fetal Brain Volume Predicts Neurodevelopment in Congenital Heart Disease

Circulation (New York, N.Y.), 2022-04, Vol.145 (15), p.1108-1119

2022

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization

Circulation (New York, N.Y.), 2022-04, Vol.145 (16), p.1205-1217

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

Circulation (New York, N.Y.), 2017-07, Vol.136 (3), p.332-335

2017

Link zum Volltext

Verfügbarkeit prüfen

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes

Circulation (New York, N.Y.), 2022-08, Vol.146 (9), p.676-686

2022

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk: Insights From the FOURIER Trial

Circulation (New York, N.Y.), 2019-03, Vol.139 (12), p.1483-1492

2019

Link zum Volltext

Verfügbarkeit prüfen

A Call to Action for New Global Approaches to Cardiovascular Disease Drug Solutions

Circulation (New York, N.Y.), 2021-07, Vol.144 (2), p.159-169

2021

Link zum Volltext

Verfügbarkeit prüfen

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2021-05, Vol.143 (21), p.e984-e1010

2021

Link zum Volltext

Verfügbarkeit prüfen

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction: Subanalysis From the DECLARE-TIMI 58 Trial

Circulation (New York, N.Y.), 2019-05, Vol.139 (22), p.2516-2527

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

Circulation (New York, N.Y.), 2022-10, Vol.146 (14), p.1046-1055

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry

Circulation (New York, N.Y.), 2010-02, Vol.121 (5), p.635-643

2010

Link zum Volltext

Verfügbarkeit prüfen

Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2019-02, Vol.139 (7), p.932-948

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44.911

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCirculation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44.265)
Mit Volltextzugriff
(44.645)

Publikationsform

Artikel
(44.911)

Sprache

Englisch
(44.911)
Japanisch
(8.375)
Russisch
(13)
Norwegisch
(3)
Tschechisch
(1)
Französisch
(1)
Polnisch
(1)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Cardiovascular System & Cardiology
(41.931)
Life Sciences & Biomedicine
(41.931)
Science & Technology
(41.931)
Cardiac & Cardiovascular Systems
(41.929)
Peripheral Vascular Disease
(41.924)
Humans
(31.317)
Biological And Medical Sciences
(18.864)
Medical Sciences
(18.263)
Male
(18.037)
Female
(15.479)
Cardiology. Vascular System
(14.013)
Middle Aged
(11.918)
Animals
(8.726)
Aged
(8.490)
Physiology
(8.418)
Adult
(8.407)
Cardiology And Cardiovascular Medicine
(8.307)
Blood And Lymphatic Vessels
(8.289)
Heart
(8.160)
Diseases Of The Peripheral Vessels. Diseases Of The Vena Cava. Miscellaneous
(7.310)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(44.911)
Journals@Ovid Complete
(44.911)
Ingenta
(42.359)
IngentaConnect Journals
(41.310)
British Medical Journals Online Archive (BMJ)
(1)
Elsevier ScienceDirect Journals Complete
(1)
BMJ Journals Archiv - DFG Nationallizenzen
(1)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Circulation;
(161)
Circulation. Genomic And Precision Medicine
(13)
Eucor Newsletter
(12)
Circulation : The Journal Of The American Heart Association
(8)
Amer.Heart Ass.Monogr
(4)
Stroke
(2)
Circulation 40: 277-88
(1)
Circulation 41: 115-22
(1)
Circulation, 35: 55-60
(1)

4 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(20)

Menü

Weitere Dienste

Einstellungen

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity

Cardiorenal Syndrome Revisited

Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial

Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry

Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction

Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement

Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction

Fetal Brain Volume Predicts Neurodevelopment in Congenital Heart Disease

Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization

Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk: Insights From the FOURIER Trial

A Call to Action for New Global Approaches to Cardiovascular Disease Drug Solutions

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and Thrombogenicity: Role of the Ang II/AT1 Receptor/NADPH Oxidase-Mediated Activation of MAPKs and PI3-Kinase Pathways

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction: Subanalysis From the DECLARE-TIMI 58 Trial

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry

Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension

Aktive Filter

Suchergebnisse filtern